Inventor

MANLEY PAUL WILLIAM

CH27 patents

⚠️ This page may combine multiple inventors who share the name “MANLEY PAUL WILLIAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MANLEY PAUL WILLIAM

NOVARTIS AG

Anthranilic acid amides and the use thereof as medicaments

Inhibitors of tyrosine kinases

VEGF receptor tyrosine kinase inhibitors

VEGF receptor tyrosine kinase inhibitors

4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives

2-amino-nicotinamide derivatives and their use as VEGF-receptor tyrosine kinase inhibitors

Isoquinoline derivatives with angiogenesis inhibiting activity

Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases

Phthalazine derivatives for treating inflammatory diseases

Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity

Phthalazine derivatives with angiogenesis inhibiting activity

Phthalazine derivatives with angiogenesis inhibiting activity

Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase

N-phenyl-3-pyrimidine-amine derivatives

N-oxides of N-phenyl-2-pyrimidine-amine derivatives

Phthalazine derivatives for treating inflammatory diseases

Pyrimidineamide derivatives and the use thereof

FURET PASCAL

Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

DING QIANG

Compounds and compositions as protein kinase inhibitors

SCHERING AG

N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF

DODD STEPHANIE KAY

Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1

GRIFFIN JAMES DOUGLAS

Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity

BUERGER HANS MICHAEL

Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide